当前位置:首页 » 翻译 
  • 匿名
关注:1 2013-05-23 12:21

求翻译:Fgf signalling is known to play critical Fibroblast growth factors (FGFs) and their high-affinity receptors [fibroblast growth factor receptors (FGFRs)] contribute to autocrine and paracrine growth stimulation in several non-liver cancer entities. Here we report that at least one member of the FGF8 subfamily (FGF8, FGF17, and FGF18) was up-regulated in 59% of 34 human hepatocellular carcinoma (HCC) samples that we investigated. The levels of the corresponding receptors (FGFR2, FGFR3, and FGFR4) were also elevated in the great majority of the HCC cases. Overall, 82% of the HCC cases showed overexpression of at least one FGF and/or FGFR. The functional implications of the deregulated FGF/FGFR system were investigated by the simulation of an insufficient blood supply. When HCC-1.2, HepG2, or Hep3B cells were subjected to serum withdrawal or the hypoxia-mimetic drug deferoxamine mesylate, the expression of FGF8 subfamily members increased dramatically. In the serum-starved cells, the incidence of apoptosis was elevated, whereas the addition of FGF8, FGF17, or FGF18 impaired apoptosis, which was associated with phosphorylation of extracellular signal-regulated kinase 1/2 and ribosomal protein S6. In contrast, down-modulation of FGF18 by small interfering RNA (siRNA) significantly reduced the viability of the hepatocarcinoma cells. siRNA targeting FGF18 also impaired the cells' potential to form clones at a low cell density or in soft agar. With respect to the tumor microenvironment, FGF17 and FGF18 stimulated the growth of HCC-derived myofibroblasts, and FGF8, FGF17, and FGF18 induced the proliferation and tube formation of hepatic endothelial cells. CONCLUSION: FGF8, FGF17, and FGF18 are involved in autocrine and paracrine signaling in HCC and enhance the survival of tumor cells under stress conditions, malignant behavior, and neoangiogenesis. Thus, the FGF8 subfamily supports the development and progression of hepatocellular malignancy.是什么意思?

待解决 悬赏分:1 - 离问题结束还有
Fgf signalling is known to play critical Fibroblast growth factors (FGFs) and their high-affinity receptors [fibroblast growth factor receptors (FGFRs)] contribute to autocrine and paracrine growth stimulation in several non-liver cancer entities. Here we report that at least one member of the FGF8 subfamily (FGF8, FGF17, and FGF18) was up-regulated in 59% of 34 human hepatocellular carcinoma (HCC) samples that we investigated. The levels of the corresponding receptors (FGFR2, FGFR3, and FGFR4) were also elevated in the great majority of the HCC cases. Overall, 82% of the HCC cases showed overexpression of at least one FGF and/or FGFR. The functional implications of the deregulated FGF/FGFR system were investigated by the simulation of an insufficient blood supply. When HCC-1.2, HepG2, or Hep3B cells were subjected to serum withdrawal or the hypoxia-mimetic drug deferoxamine mesylate, the expression of FGF8 subfamily members increased dramatically. In the serum-starved cells, the incidence of apoptosis was elevated, whereas the addition of FGF8, FGF17, or FGF18 impaired apoptosis, which was associated with phosphorylation of extracellular signal-regulated kinase 1/2 and ribosomal protein S6. In contrast, down-modulation of FGF18 by small interfering RNA (siRNA) significantly reduced the viability of the hepatocarcinoma cells. siRNA targeting FGF18 also impaired the cells' potential to form clones at a low cell density or in soft agar. With respect to the tumor microenvironment, FGF17 and FGF18 stimulated the growth of HCC-derived myofibroblasts, and FGF8, FGF17, and FGF18 induced the proliferation and tube formation of hepatic endothelial cells. CONCLUSION: FGF8, FGF17, and FGF18 are involved in autocrine and paracrine signaling in HCC and enhance the survival of tumor cells under stress conditions, malignant behavior, and neoangiogenesis. Thus, the FGF8 subfamily supports the development and progression of hepatocellular malignancy.
问题补充:

  • 匿名
2013-05-23 12:26:38
Fgf 信号已知发挥关键碱性成纤维细胞生长因子 (FGFs),其高亲和力受体 [碱性成纤维细胞生长因子受体 (FGFRs)] 贡献几个非肝癌实体自分泌和旁分泌生长刺激。在这里我们报告,至少一个成员的 FGF8 亚科 (FGF8、 FGF17、 FGF18) 是我们调查的 34 人肝细胞癌 (合同) 样品 59%上调。(FGFR2、 成,和 FGFR4) 的相应受体水平的上升了也,绝大多数的肝癌病例。总体而言,82%的肝癌病例表明至少一个电影和/或 FGFR 的表达。电力市场的电影/FGFR 系统的功能影响仿真计算的供血不足进行了调查。当肝癌 1.2、 runx3 基因表达或 Hep3B 细胞遭到血清撤回或缺氧仿生药物去铁胺甲磺酸时,FGF8 亚科成员的表达式将急剧增加。血清饿的细胞,被提升细胞凋亡的发生率,而加 FGF8、 FGF17 或 FGF18 受损细胞凋亡,这是与磷酸化细胞外信号调节激酶 1/2 和核糖体蛋白中六相关联。与此相反下, 调制的小分子干扰 rna (siRNA) FGF18 大大降低肝癌细胞的活力。此外针对 FGF18 的 siRNA 受损窗体无性系在低密度或软琼脂细胞的潜力。关于肿瘤微环境中,FGF17 和 FGF18 刺激肝癌衍生成纤维细胞生长和 FGF8、 FGF17 和 FGF18 诱导增殖和肝血管内皮细胞管形成。结论: FGF8、 FGF17、 FGF18 参与自分泌和旁分泌肝细胞肝癌中信令和提高下应力条件、 恶性行为和血管生成的肿瘤细胞存活。因此,FGF8 亚科支持发展和肝细胞恶性肿瘤的研究进展。
 
 
网站首页

湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区

 
关 闭